2023-07-012024-06-302024-06-30false14194990TWEIDPHARMA LIMITED2025-09-10falseiso4217:GBPxbrli:pure141949902023-06-30141949902024-06-30141949902023-07-012024-06-30141949902022-06-23141949902023-06-30141949902022-06-242023-06-3014194990bus:SmallEntities2023-07-012024-06-3014194990bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3014194990bus:FullAccounts2023-07-012024-06-3014194990bus:PrivateLimitedCompanyLtd2023-07-012024-06-3014194990core:WithinOneYear2024-06-3014194990core:AfterOneYear2024-06-3014194990core:WithinOneYear2023-06-3014194990core:AfterOneYear2023-06-3014194990core:ShareCapital2024-06-3014194990core:SharePremium2024-06-3014194990core:RevaluationReserve2024-06-3014194990core:OtherReservesSubtotal2024-06-3014194990core:RetainedEarningsAccumulatedLosses2024-06-3014194990core:ShareCapital2023-06-3014194990core:SharePremium2023-06-3014194990core:RevaluationReserve2023-06-3014194990core:OtherReservesSubtotal2023-06-3014194990core:RetainedEarningsAccumulatedLosses2023-06-3014194990core:LandBuildings2024-06-3014194990core:PlantMachinery2024-06-3014194990core:Vehicles2024-06-3014194990core:FurnitureFittings2024-06-3014194990core:OfficeEquipment2024-06-3014194990core:NetGoodwill2024-06-3014194990core:IntangibleAssetsOtherThanGoodwill2024-06-3014194990core:ListedExchangeTraded2024-06-3014194990core:UnlistedNon-exchangeTraded2024-06-3014194990core:LandBuildings2023-06-3014194990core:PlantMachinery2023-06-3014194990core:Vehicles2023-06-3014194990core:FurnitureFittings2023-06-3014194990core:OfficeEquipment2023-06-3014194990core:NetGoodwill2023-06-3014194990core:IntangibleAssetsOtherThanGoodwill2023-06-3014194990core:ListedExchangeTraded2023-06-3014194990core:UnlistedNon-exchangeTraded2023-06-3014194990core:LandBuildings2023-07-012024-06-3014194990core:PlantMachinery2023-07-012024-06-3014194990core:Vehicles2023-07-012024-06-3014194990core:FurnitureFittings2023-07-012024-06-3014194990core:OfficeEquipment2023-07-012024-06-3014194990core:NetGoodwill2023-07-012024-06-3014194990core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3014194990core:ListedExchangeTraded2023-07-012024-06-3014194990core:UnlistedNon-exchangeTraded2023-07-012024-06-3014194990core:MoreThanFiveYears2023-07-012024-06-3014194990core:Non-currentFinancialInstruments2024-06-3014194990core:Non-currentFinancialInstruments2023-06-3014194990dpl:CostSales2023-07-012024-06-3014194990dpl:DistributionCosts2023-07-012024-06-3014194990core:LandBuildings2023-07-012024-06-3014194990core:PlantMachinery2023-07-012024-06-3014194990core:Vehicles2023-07-012024-06-3014194990core:FurnitureFittings2023-07-012024-06-3014194990core:OfficeEquipment2023-07-012024-06-3014194990dpl:AdministrativeExpenses2023-07-012024-06-3014194990core:NetGoodwill2023-07-012024-06-3014194990core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3014194990dpl:GroupUndertakings2023-07-012024-06-3014194990dpl:ParticipatingInterests2023-07-012024-06-3014194990dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3014194990core:ListedExchangeTraded2023-07-012024-06-3014194990dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3014194990core:UnlistedNon-exchangeTraded2023-07-012024-06-3014194990dpl:CostSales2022-06-242023-06-3014194990dpl:DistributionCosts2022-06-242023-06-3014194990core:LandBuildings2022-06-242023-06-3014194990core:PlantMachinery2022-06-242023-06-3014194990core:Vehicles2022-06-242023-06-3014194990core:FurnitureFittings2022-06-242023-06-3014194990core:OfficeEquipment2022-06-242023-06-3014194990dpl:AdministrativeExpenses2022-06-242023-06-3014194990core:NetGoodwill2022-06-242023-06-3014194990core:IntangibleAssetsOtherThanGoodwill2022-06-242023-06-3014194990dpl:GroupUndertakings2022-06-242023-06-3014194990dpl:ParticipatingInterests2022-06-242023-06-3014194990dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-242023-06-3014194990core:ListedExchangeTraded2022-06-242023-06-3014194990dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-242023-06-3014194990core:UnlistedNon-exchangeTraded2022-06-242023-06-3014194990core:NetGoodwill2024-06-3014194990core:IntangibleAssetsOtherThanGoodwill2024-06-3014194990core:LandBuildings2024-06-3014194990core:PlantMachinery2024-06-3014194990core:Vehicles2024-06-3014194990core:FurnitureFittings2024-06-3014194990core:OfficeEquipment2024-06-3014194990core:AfterOneYear2024-06-3014194990core:WithinOneYear2024-06-3014194990core:ListedExchangeTraded2024-06-3014194990core:UnlistedNon-exchangeTraded2024-06-3014194990core:ShareCapital2024-06-3014194990core:SharePremium2024-06-3014194990core:RevaluationReserve2024-06-3014194990core:OtherReservesSubtotal2024-06-3014194990core:RetainedEarningsAccumulatedLosses2024-06-3014194990core:NetGoodwill2023-06-3014194990core:IntangibleAssetsOtherThanGoodwill2023-06-3014194990core:LandBuildings2023-06-3014194990core:PlantMachinery2023-06-3014194990core:Vehicles2023-06-3014194990core:FurnitureFittings2023-06-3014194990core:OfficeEquipment2023-06-3014194990core:AfterOneYear2023-06-3014194990core:WithinOneYear2023-06-3014194990core:ListedExchangeTraded2023-06-3014194990core:UnlistedNon-exchangeTraded2023-06-3014194990core:ShareCapital2023-06-3014194990core:SharePremium2023-06-3014194990core:RevaluationReserve2023-06-3014194990core:OtherReservesSubtotal2023-06-3014194990core:RetainedEarningsAccumulatedLosses2023-06-3014194990core:NetGoodwill2022-06-2314194990core:IntangibleAssetsOtherThanGoodwill2022-06-2314194990core:LandBuildings2022-06-2314194990core:PlantMachinery2022-06-2314194990core:Vehicles2022-06-2314194990core:FurnitureFittings2022-06-2314194990core:OfficeEquipment2022-06-2314194990core:AfterOneYear2022-06-2314194990core:WithinOneYear2022-06-2314194990core:ListedExchangeTraded2022-06-2314194990core:UnlistedNon-exchangeTraded2022-06-2314194990core:ShareCapital2022-06-2314194990core:SharePremium2022-06-2314194990core:RevaluationReserve2022-06-2314194990core:OtherReservesSubtotal2022-06-2314194990core:RetainedEarningsAccumulatedLosses2022-06-2314194990core:AfterOneYear2023-07-012024-06-3014194990core:WithinOneYear2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3014194990core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3014194990core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3014194990core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3014194990core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3014194990core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3014194990bus:Director12023-07-012024-06-3014194990bus:Director22023-07-012024-06-3014194990bus:Director32023-07-012024-06-30

TWEIDPHARMA LIMITED

Registered Number
14194990
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

TWEIDPHARMA LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Directors

DUNCALF, Ian James
FERGUS, Darren
TWEEDIE, Oliver John

Registered Address

Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage
SG1 2FX

Registered Number

14194990 (England and Wales)
TWEIDPHARMA LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors2,4648,272
Cash at bank and on hand2,614644
5,0788,916
Creditors amounts falling due within one year3(13,437)(6,070)
Net current assets (liabilities)(8,359)2,846
Total assets less current liabilities(8,359)2,846
Net assets(8,359)2,846
Capital and reserves
Called up share capital10,00010,000
Profit and loss account(18,359)(7,154)
Shareholders' funds(8,359)2,846
The financial statements were approved and authorised for issue by the Board of Directors on 10 September 2025, and are signed on its behalf by:
FERGUS, Darren
Director
Registered Company No. 14194990
TWEIDPHARMA LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
2.Average number of employees

20242023
Average number of employees during the year33
3.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables4,106-
Other creditors8,6715,470
Accrued liabilities and deferred income660600
Total13,4376,070